Table I.
Maternal and infant characteristics (N = 160 unless specified)
| Characteristics | Value |
|---|---|
| Maternal | |
| Age, y, mean ± SD (median) | 30.8 ± 6.2 (31) |
| Gravida, mean ± SD (median) | 3.4 ± 2.5 (3) |
| Parity, mean ± SD (median) | 1.7 ± 1.9 (1) |
| Gestational age, mean ± SD (median) | 38.8 ± 1.7 (39.1) |
| Ethnicity, n (%) | |
| Non-Hispanic | 91 (56.9) |
| Hispanic | 65 (40.6) |
| Unknown | 4 (2.5) |
| Race, n (%) | |
| White | 84 (52.5) |
| Black | 13 (8.1) |
| Asian | 2 (1.3) |
| Native Hawaiian/other Pacific Islander | 9 (5.6) |
| Other | 52 (32.5) |
| Symptoms | |
| Never symptomatic, n (%) | 76 (47.5) |
| Symptomatic only during admission, n (%) | 21 (13.1) |
| Symptomatic before and during admission, n (%) | 38 (23.8) |
| Symptomatic only before admission, n (%) | 25 (15.6) |
| Day of symptoms,∗ mean ± SD (median) | −14.6 ± 17.1 (−7) |
| Fever (>100 °F), n (%) | 49 (30.6) |
| Cough, n (%) | 65 (40.6) |
| Shortness of breath, n (%) | 13 (8.1) |
| Maternal medications, n (%) | |
| None | 134 (89.4) |
| Hydroxychloroquine | 15 (9.4) |
| Azithromycin | 10 (6.3) |
| Tocilizumab | 3 (1.9) |
| Remdesivir | 2 (1.3) |
| Lopinavir-ritonavir | 3 (1.9) |
| Heparin | 5 (3.1) |
| Reason for delivery, n (%) | |
| Expected | 148 (92.5) |
| Preterm (infant indication) | 2 (1.3) |
| Preterm (maternal indication) | 6 (3.8) |
| Maternal COVID-19 | 4 (2.5) |
| Method of delivery | |
| Vaginal delivery | 120 (75.0) |
| Elective primary cesarean | 1 (0.6) |
| Repeat cesarean | 11 (6.9) |
| Cesarean for failed induction | 2 (1.3) |
| Cesarean for failure to progress | 4 (2.5) |
| Cesarean for Non Reassuring Fetal Heart Tracing | 7 (4.4) |
| Cesarean for breech | 3 (1.9) |
| Emergency Cesarean | 6 (3.8) |
| Cesarean for maternal indication (eg, preeclampsia, placenta previa) | 4 (2.5) |
| Extramural delivery | 2 (1.3) |
| Rupture of membranes, h, mean ± SD (median) (N = 159) | 5.5 ± 7.1 (2) |
| Infant characteristics | |
| Sex, n (%) | |
| Male | 71 (44.4) |
| Female | 89 (55.6) |
| Birth weight, kg, mean ± SD (median) | 3.3 ± 0.5 (3.28) |
| Length, cm, mean ± SD (median) | 0.51 ± 0.03 (0.51) |
| Head circumference, cm, mean ± SD (median) | 33.6 ± 1.6 (33.5) |
| Apagar 0 min, median (IQR) (N = 159) | 9 (8-9) |
| Apgar 5 min, median (IQR) (N = 159) | 9 (9-9) |
| SGA/AGA/LGA, n (%) | |
| SGA | 10 (6.3) |
| AGA | 143 (89.4) |
| LGA | 7 (4.4) |
| Need for resuscitation (PPV), n (%) | 15 (9.4) |
| Newborn nursery or NICU, N (%) | |
| Newborn nursery | 145 (90.6) |
| NICU | 15 (9.4) |
| Isolation type, n (%) | |
| No isolation | 7 (4.4) |
| Contact only | 1 (0.6) |
| Contact/airborne/eye protection | 88 (55.0) |
| Contact/droplet/eye protection | 64 (40.0) |
| First test age, h, mean ± SD (median) | 21.5 ± 7.8 (24) |
| Second test age, h, mean ± SD (median) (N = 90) | 50.3 ± 18.0 (48) |
| Maximum temperature during hospitalization, °C, mean ± SD (median) | 37.3 ± 0.3 (37.2) |
| Total LOS, d, mean ± SD (median) | 3.0 ± 7.1 (2) |
| NICU LOS, d, mean ± SD (median) (N = 18) | 13.4 ± 18.4 (4.5) |
SGA, small for gestational age; AGA, average for gestational age; LGA, large for gestational age; PPV, positive pressure ventilation.
∗
Negative number represents days before delivery.